Revenue Breakdown
Composition ()
No data
Revenue Streams
Femasys Inc (FEMY) generates its revenue primarily from Medical Equipment, Supplies & Distribution, which accounts for 100.0% of total sales, equivalent to $213.11K. Understanding this concentration is critical for investors evaluating how FEMY navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, Femasys Inc maintains a gross margin of 47.97%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -500.93%, while the net margin is -575.11%. These profitability ratios, combined with a Return on Equity (ROE) of -376.23%, provide a clear picture of how effectively FEMY converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, FEMY competes directly with industry leaders such as WBX and ACFN. With a market capitalization of $32.12M, it holds a significant position in the sector. When comparing efficiency, FEMY's gross margin of 47.97% stands against WBX's 11.27% and ACFN's 78.49%. Such benchmarking helps identify whether Femasys Inc is trading at a premium or discount relative to its financial performance.
